Morning Read: Evolent Health acquires majority stake in Valence Health in $145M deal, Merck sheds 360 jobs
Also, Biotech industry veteran Steve Holtzman, has become CEO of Decibel Therapeutics and the U.S. Department of Health and Human Services Office for Civil Rights offers guidance for hospitals on ransomware attacks.